These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 3026626)
1. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system. Wolff SN; Phillips GL; Herzig GP Cancer Treat Rep; 1987 Feb; 71(2):183-5. PubMed ID: 3026626 [TBL] [Abstract][Full Text] [Related]
2. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients. Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621 [TBL] [Abstract][Full Text] [Related]
3. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients. Fernández-Hidalgo OA; Vanaclocha V; Vieitez JM; Aristu JJ; Rebollo J; Gúrpide A; Aramendía JM; Moreno-Palanques R; Martín-Algarra S; Subirá ML; Brugarolas A Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007 [TBL] [Abstract][Full Text] [Related]
4. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation. Johnson DB; Thompson JM; Corwin JA; Mosley KR; Smith MT; de los Reyes RA; Daly MB; Petty AM; Lamaster D; Pierson WP J Clin Oncol; 1987 May; 5(5):783-9. PubMed ID: 3553437 [TBL] [Abstract][Full Text] [Related]
5. Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation. Giannone L; Wolff SN Cancer Treat Rep; 1987; 71(7-8):759-61. PubMed ID: 3038317 [TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma. Liau CT; Wei KC; Tseng CK; Jung SM Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144 [TBL] [Abstract][Full Text] [Related]
8. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma. Mbidde EK; Selby PJ; Perren TJ; Dearnaley DP; Whitton A; Ashley S; Workman P; Bloom HJ; McElwain TJ Br J Cancer; 1988 Dec; 58(6):779-82. PubMed ID: 2852028 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine]. Rebollo J; Martín-Algarra S; Bilbao I; Zubieta JL; Calvo FA; de Castro P; Pastor MA; Viteri C; Martínez Lage JM Neurologia; 1990; 5(7):228-32. PubMed ID: 1963067 [TBL] [Abstract][Full Text] [Related]
10. Intravenous administration of high doses of carboplatin in multimodal treatment of high grade gliomas: a phase II study. Lunardi P; Osman Farah J; Mastronardi L; Puzzilli F; Lo Bianco FM Acta Neurochir (Wien); 1996; 138(2):215-20. PubMed ID: 8686548 [TBL] [Abstract][Full Text] [Related]
11. High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence. Finlay JL; August C; Packer R; Zimmerman R; Sutton L; Freid A; Rorke L; Bayever E; Kamani N; Kramer E J Neurooncol; 1990 Dec; 9(3):239-48. PubMed ID: 1964962 [TBL] [Abstract][Full Text] [Related]
12. Does high-dose carmustine increase overall survival in supratentorial high-grade malignant glioma? An EBMT retrospective study. Bay JO; Linassier C; Biron P; Durando X; Verrelle P; Kwiatkowski F; Rosti G; Demirer T; Int J Cancer; 2007 Apr; 120(8):1782-6. PubMed ID: 17230505 [TBL] [Abstract][Full Text] [Related]
13. BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas. Vitanovics D; Sipos L; Afra D Neoplasma; 2002; 49(5):342-5. PubMed ID: 12458335 [TBL] [Abstract][Full Text] [Related]
14. A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study. Dazzi C; Cariello A; Giannini M; Del Duca M; Giovanis P; Fiorentini G; Leoni M; Rosti G; Turci D; Tienghi A; Vertogen B; Zumaglini F; De Giorgi U; Marangolo M Anticancer Res; 2000; 20(1B):515-8. PubMed ID: 10769716 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results. Ogawa K; Ishiuchi S; Inoue O; Yoshii Y; Saito A; Watanabe T; Iraha S; Toita T; Kakinohana Y; Ariga T; Kasuya G; Murayama S Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):732-8. PubMed ID: 21420247 [TBL] [Abstract][Full Text] [Related]
18. Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51. Rao RD; Krishnan S; Fitch TR; Schomberg PJ; Dinapoli RP; Nordstrom K; Scheithauer B; O'Fallon JR; Maurer MJ; Buckner JC Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):380-6. PubMed ID: 15667956 [TBL] [Abstract][Full Text] [Related]
19. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642 [TBL] [Abstract][Full Text] [Related]